Present and future of endovascular SFA treatment: Stents, stent-grafts, drug coated balloons and drug coated stents

Journal of Cardiovascular Surgery

Volumn 49, Issue 2, 2008, Pages 159-165

  Bosiers, Marc ^a   Deloose, K ^a   Verbist, J ^a   Peeters, P ^b  

^a AZ St Blasius ^*  (Belgium)

^b IMELDA HOSPITAL   (Belgium)

Author keywords

Drug eluting stents; Endovascular surgical procedures; Femoral artery

Indexed keywords

ANTITHROMBOCYTIC AGENT; DACRON; EVEROLIMUS; NITINOL; PACLITAXEL; POLITEF; RAPAMYCIN;

ANGIOPLASTY; ARTERIOSCLEROSIS; ARTERY DISEASE; ARTERY OCCLUSION; BALLOON DILATATION; CLINICAL TRIAL; CONSENSUS DEVELOPMENT; DOPPLER ECHOGRAPHY; DRUG ELUTING STENT; ENDOVASCULAR SURGERY; EQUIPMENT DESIGN; GRAFT PATENCY; HUMAN; IN-STENT RESTENOSIS; MATERIAL COATING; MEDICAL SOCIETY; MINIMALLY INVASIVE SURGERY; PATIENT SAFETY; POSTOPERATIVE THROMBOSIS; QUALITY ADJUSTED LIFE YEAR; REVIEW; STENT; SUPERFICIAL FEMORAL ARTERY; SURGICAL EQUIPMENT; SURGICAL TECHNIQUE; TREATMENT INDICATION; TREATMENT OUTCOME;

ALLOYS; ANGIOPLASTY, BALLOON; BIOMECHANICS; COATED MATERIALS, BIOCOMPATIBLE; DRUG-ELUTING STENTS; EQUIPMENT DESIGN; EQUIPMENT FAILURE; FEMORAL ARTERY; HUMANS; PACLITAXEL; STENTS; VASCULAR PATENCY;

EID: 45149129731     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (15)

1. Dormandy JA, Rutherford RB. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 2000;31:S1-S296.
2. Do-dai-Do, Triller J, Walpoth BH, Stimemann P, Mahler F. A comparison study of self-expandable stents vs balloon angioplasty alone in femoropopliteal artery occlusions. Cardiovasc Intervent Radiol 1992; 15:306-12.
3. Mewissen M. Self-expanding nitinol stents in the femoropopliteal segment: technique and mid-term results. Tech Vasv Interv Radiol 2004;7:2-5.
4. Norgren L, Hiatt WR, Dormandy JA, Nehler MR Harris KA, Fowkes FG et al. TransAtlantic Inter-Society Consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 2007;45(Suppl S):S5-67.
5. Scheinert D, Scheinert S, Sax J, Piorkowski C, Braunlich S, Ulrich M et al. Prevalence and clinical impact of stent fractures after femoropopliteal stenting. J Am Coll Cardiol 2005;45:312-5.
6. Duda S, Bosiers M, Pusich B, Huttl K, Oliva V, Muller-Hulsbeck S et al. Endovascular treatment of peripheral artery disease with expanded PTFE-covered nitinol stents: interim analysis from a prospective controlled study. Cardiovasc Intervent Radiol 2002;25:413-8.
7. Duda S, Bosiers M, Lammer J, Scheinert D, Zeller T, Tielbeek A et al. Sirolimus-eluting versus bare nitinol stent for obstructive superficial femoral artery disease: the SIROCCO II trial. J Vasc Interv Radiol 2005;16:331-8.
8. Duda S, Bosiers M, Lammer J, Scheinert D, Zeller T, Oliva V et al. Drug-eluting and bare nitinol stents for the treatment of atherosclerotic lesions in the superficial femoral artery: long-term results from the SIROCCO trial. J Endovasc Ther 2006;13:701-10.
9. Ahmadi R, Schillinger M, Maca T, Minar E. Femoropopliteal arteries: immediate and long-term results with a Dacron-covered stent-graft. Radiology 2002; 223:345-50.
10. Sabeti S, schillinger M, Amighi J, Sherif C, Mlekusch W, Ahmadi R et al. SMAJSCMWARME. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: propensity score-adjusted analysis. Radiology 2004;232:516-21.
11. Wiesinger B, Beregi JP, Oliva VL, Dietrich T, Tepe G, Bosiers M et al. PTFE-covered self-expanding nitinol stents for the treatment of severe iliac and femoral artery stenoses and occlusions: final results from a prospective study. J Endovasc Ther 2005;12:240-6.
12. Lammer J, Dake MD, Bleyn J, Katzen BT, Cejna M, Piquet P et al. Peripheral arterial obstruction: prospective study of treatment with a transluminally placed self-expanding stent-graft. International Trial Study Group. Radiology 2000;217:95-104.
13. Clark TW, Groffsky JL, Soulen MC. Predictors of long-term patency after femoropopliteal angioplasty: results from the STAR registry. J Vasc Interv Radiol 2001;12:923-33.
14. Fischer M, Schwabe C, Schulte K. Value of the Hemobahn/Viabahn endoprosthesis in the treatment of long chronic lesions of the superficial femoral artery: 6 years of experience. J Endovasc Ther 2006;13:281-90.
15. Kedora J, Hohmann S, Garrett W, Munschaur C, Theune B, Gable D. Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease. J Vasc Surg 2007;45:10-6.